Research / ARDX / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-25-006653 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
45.22% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.30% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.43% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
168.06% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
27.33% · OPTIONAL · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-8.38% · CORE · VALID
R&D intensity 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.68% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.20% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 7/8 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 102.51%
Current 45.22%
Delta -57.29% Capex Intensity Increased
Previous 0.14%
Current 0.30%
Delta 0.16% Cash Generation Decreased
Previous 0.51%
Current -13.43%
Delta -13.94% Growth Increased
Previous 74.21%
Current 168.06%
Delta 93.84% Inventory Pressure Decreased
Previous 86.68%
Current 27.33%
Delta -59.35% Profitability Decreased
Previous 2.27%
Current -8.38%
Delta -10.65% R And D Intensity Increased
Previous 15.58%
Current 15.68%
Delta 0.10% Sbc Intensity Increased
Previous 9.30%
Current 11.20%
Delta 1.91% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.